IND-02

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIND-02
Drug Alias NameIND-02INDUS-82020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine receptors antagonistsTumor necrosis factor inhibitors
TargetsCytokine receptorsTumor necrosis factor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse Reactions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIndus Biotech Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIndus Biotech Pvt Ltd
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse Reactions
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A